Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...

While other triggers are more likely to bring on an atopic dermatitis flare, Megan Rogge, MD, of UT Health in Houston talks about when to consider food allergies and recommend an elimination diet.

While eczema is a common skin condition, it can manifest in many different ways. And with so much possible variation, it's not always easy to properly identify eczema. Eczema symptoms can be mild — a ...

If you experience chronic dry, itchy and red skin, you may be one of the millions of Americans with eczema. The National Eczema Association reports that an estimated 10% of the world population ...

Managing itch associated with atopic dermatitis is a critical intervention to patient quality of life. Casey Butrus, PharmD: Dr Cameron, what’s the typical onset of action when you’re looking at a ...

A recently approved injectable eczema drug, Nemluvio, provides quick itch relief to patients with the maddening skin disease, ...

Please provide your email address to receive an email when new articles are posted on . Tapinarof cream 1% showed low discontinuation rates. The cream has no restriction of use. Tapinarof patients ...

A small study recently found that the experimental drug nemolizumab (Mitchga) substantially improved itching in people with atopic dermatitis (AD). These improvements, in turn, were associated with ...

Topical ruxolitinib appears to quickly relieve itch in Black patients with atopic dermatitis (AD), an industry-sponsored analysis of pooled data from two studies suggests. "Ruxolitinib cream ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...